- Home
- BDL vs RPHM Comparison
BDL vs RPHM Comparison
Compare BDL & RPHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDL
- RPHM
- Stock Information
- Founded
- BDL 1959
- RPHM 2014
- Country
- BDL United States
- RPHM United States
- Employees
- BDL N/A
- RPHM N/A
- Industry
- BDL Restaurants
- RPHM Biotechnology: Pharmaceutical Preparations
- Sector
- BDL Consumer Discretionary
- RPHM Health Care
- Exchange
- BDL Nasdaq
- RPHM Nasdaq
- Market Cap
- BDL 48.7M
- RPHM 47.5M
- IPO Year
- BDL N/A
- RPHM 2021
- Fundamental
- Price
- BDL $26.45
- RPHM $1.70
- Analyst Decision
- BDL
- RPHM Hold
- Analyst Count
- BDL 0
- RPHM 6
- Target Price
- BDL N/A
- RPHM $2.26
- AVG Volume (30 Days)
- BDL 1.1K
- RPHM 316.0K
- Earning Date
- BDL 08-13-2024
- RPHM 11-11-2024
- Dividend Yield
- BDL 1.91%
- RPHM N/A
- EPS Growth
- BDL N/A
- RPHM N/A
- EPS
- BDL 1.64
- RPHM N/A
- Revenue
- BDL $185,457,000.00
- RPHM N/A
- Revenue This Year
- BDL N/A
- RPHM N/A
- Revenue Next Year
- BDL N/A
- RPHM N/A
- P/E Ratio
- BDL $15.98
- RPHM N/A
- Revenue Growth
- BDL 8.71
- RPHM N/A
- 52 Week Low
- BDL $24.43
- RPHM $0.98
- 52 Week High
- BDL $32.65
- RPHM $9.21
- Technical
- Relative Strength Index (RSI)
- BDL 47.40
- RPHM 61.53
- Support Level
- BDL $26.20
- RPHM $1.61
- Resistance Level
- BDL $28.84
- RPHM $1.75
- Average True Range (ATR)
- BDL 0.15
- RPHM 0.12
- MACD
- BDL -0.10
- RPHM 0.03
- Stochastic Oscillator
- BDL 23.89
- RPHM 81.25
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.
About RPHM Reneo Pharmaceuticals Inc.
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.